Planned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
April 2028
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 2028
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Brief Summary
The goal of this clinical trial is to determine if a behavioral intervention can increase attendance at cardiac rehabilitation (CR) after secondary/type 2 myocardial infarction in adult patients. The main question it aims to answer is:
Does the ATTEND-CR intervention increase attendance at ≥1 CR exercise session within 140 days of randomization?
Does the intervention increase completion of ≥12 CR exercise sessions within 140 days of randomization? Researchers will compare participants receiving the ATTEND-CR intervention (clinician notifications and a motivational interviewing participant phone call) to usual care to see if attendance and completion of CR improve. Participants:
Clinicians will receive informational messaging regarding CR and the referral process
Participate in a motivational interviewing phone call (intervention group only)
Have follow-up assessments via telephone and electronic health record (EHR) review to track CR attendance, clinical events, and health outcomes
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
recruiting
Estimated enrollment
60 participants
Study completion date
April 2028
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Listed locations
1 countries · 1 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
First Submitted
March 12, 2026
Actual (reported)
First Posted
March 20, 2026
Actual (reported)
Study Start
October 2026
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
April 2028
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 2028
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Type 2 myocardial infarctionSecondary myocardial infarctionCardiac Rehabilitation
Outcome Measures
Primary Outcomes (1)
Number of Participants Who Attended one or more Cardiac Rehabilitation Exercise Session
Attendance at one or more cardiac rehabilitation exercise session
Within 140 days (inclusive) post-randomization
Secondary Outcomes (3)
Number of Participants With a Cardiac Rehabilitation Referral
Within 140 days (inclusive) post-randomization
Number of Participants who Completed Cardiac Rehabilitation
Within 140 days (inclusive) post-randomization
Feasibility indicators
Recruitment Time Frame: Through completion of enrollment, an average of 18 months. Retention Time Frame: Through completion of participant follow-up, an average of 20 weeks.
Other Outcomes (14)
All-cause mortality
Within 140 days (inclusive) post-randomization
All-cause hospitalization
Within 140 days (inclusive) post randomization
Major adverse cardiovascular event
Within 140 days (inclusive) post randomization
+11 more other outcomes
Study Arms (2)
Intervention Arm (ATTEND-CR):
EXPERIMENTAL
Participants clinicians receive an informational message about cardiac rehabilitation and the cardiac rehabilitation referral process. Participants who are referred to cardiac rehabilitation receive a phone call post-discharge applying principles of motivational interviewing. The goal is to encourage cardiac rehabilitation attendance.
Participants receive standard post-MI care without clinician informative messaging or a motivational interviewing phone call from the study team. They may still be referred to and attend CR based on usual clinical practice.
Interventions
Clinician-level interventionBehavioral
The inpatient clinical team receives an EPIC in-basket and email detailing the patient's study participation, benefits of cardiac rehabilitation, and guidance on how to place a cardiac referral if appropriate.
If a cardiac rehabilitation referral is not placed within 3 days post-discharge, a follow-up message is sent to one of the patient's outpatient clinician within 4-28 days post-discharge and within 140 days of randomization.
Intervention Arm (ATTEND-CR):
Patient-level interventionBehavioral
Eligibility Criteria
Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
You may qualify if:
Age ≥ 18 years
Inpatient at MGH with an index likely or confirmed secondary MI
Planned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
April 2028
Participants receive a phone call applying motivational interviewing principles if a cardiac rehabilitation referral has been placed by their clinical team within 56 days post-discharge and within 140 days of randomization.
The phone call aims to discuss cardiac rehabilitation, barriers to participation, and support engagement in cardiac rehabilitation.
Intervention Arm (ATTEND-CR):
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Primary care provider (PCP) within the Mass General Brigham (MGB) network with at least one visit in the past 2 years
Anticipated ability to ambulate independently without walking aids or supplemental ambulatory oxygen at discharge
Ability to provide informed consent
You may not qualify if:
Known severe untreated valvular heart disease or severe prosthetic valve dysfunction
Known hypertrophic obstructive cardiomyopathy
End-stage heart failure (VAD, transplant patient, or undergoing evaluation for VAD or transplant)
Hemodynamic instability at the time of pre-screening
Terminal illness with life expectancy \< 1 year
Severe anemia (hemoglobin \< 8 g/dL) at the time of pre-screening
Active, unstable cancer (excluding non-metastatic skin cancer) or currently receiving intensive cancer therapy
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 2028
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
September 23, 2026
Record last verified: 2026-09
Data Sharing
IPD Sharing
Will share
De-identified data generated from this study will be submitted to a data repository in accordance with NIH data sharing guidelines.
Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Anticipated to be available at the time of publication of the study results.
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.